HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 200 filers reported holding HERON THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $337,274 | +5.0% | 327,450 | +18.2% | 0.48% | +31.5% |
| Q2 2023 | $321,337 | -34.9% | 277,015 | -15.2% | 0.36% | -37.0% |
| Q1 2023 | $493,252 | -26.1% | 326,657 | +22.3% | 0.58% | -29.3% |
| Q4 2022 | $667,570 | -33.9% | 267,028 | +11.6% | 0.81% | -25.9% |
| Q3 2022 | $1,010,000 | +100.0% | 239,346 | +32.2% | 1.10% | +115.1% |
| Q2 2022 | $505,000 | -35.7% | 181,010 | +31.9% | 0.51% | +6.7% |
| Q1 2022 | $785,000 | +42.5% | 137,255 | +127.4% | 0.48% | +94.3% |
| Q4 2021 | $551,000 | -18.4% | 60,358 | -4.3% | 0.25% | +0.4% |
| Q3 2021 | $675,000 | +3.5% | 63,098 | +50.2% | 0.24% | +14.0% |
| Q2 2021 | $652,000 | +82.6% | 42,000 | +90.9% | 0.22% | +55.8% |
| Q1 2021 | $357,000 | -23.4% | 22,000 | 0.0% | 0.14% | -60.9% |
| Q4 2020 | $466,000 | – | 22,000 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $1,900 | 100.00% |
| Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
| GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
| Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
| TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
| Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
| Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
| CM Management, LLC | 250,000 | $625 | 0.75% |
| Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |